Loading...
Please wait, while we are loading the content...
Similar Documents
Targeted therapy for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus
| Content Provider | Scilit |
|---|---|
| Author | Dittmer, Dirk P. Krown, Susan E. |
| Copyright Year | 2007 |
| Description | Journal: Current Opinion in Oncology Purpose of review To summarize major recent findings on the biology of human herpesvirus-8, i.e. Kaposi's sarcoma-associated herpesvirus, and the implications of these findings for Kaposi's sarcoma treatment. Recent findings Although reduced in incidence in developed countries since the introduction of highly active antiretroviral therapy, Kaposi's sarcoma incidence is still markedly increased in HIV-infected patients in resource-rich areas of the world and is a major complication among HIV-infected individuals in sub-Saharan Africa. The Akt/mammalian target of rapamycin pathway has emerged as a major driving force in Kaposi's sarcoma. In addition, the roles of p53, the Kaposi's sarcoma-associated herpesvirus viral cyclin and nuclear factor-κB in the development and progression of Kaposi's sarcoma are being further clarified, and therapeutic agents are being developed that may target these pathogenetic mechanisms. New Kaposi's sarcoma treatments should be considered that target the molecular interface between virus and host. Summary The growing knowledge of Kaposi's sarcoma biology provides multiple opportunities for rational targeted therapies. Further research is needed to better understand the mechanisms by which Kaposi's sarcoma develops and to develop therapeutic strategies that prevent resistance to treatment. |
| Related Links | http://europepmc.org/articles/pmc2855645?pdf=render https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855645/pdf |
| Ending Page | 457 |
| Page Count | 6 |
| Starting Page | 452 |
| ISSN | 10408746 |
| e-ISSN | 1531703X |
| DOI | 10.1097/cco.0b013e3281eb8ea7 |
| Journal | Current Opinion in Oncology |
| Issue Number | 5 |
| Volume Number | 19 |
| Language | English |
| Publisher | Ovid Technologies (Wolters Kluwer Health) |
| Publisher Date | 2007-09-01 |
| Access Restriction | Open |
| Subject Keyword | Journal: Current Opinion in Oncology Akt/mammalian Target of Rapamycin Kaposi\'s Sarcoma Kaposi\'s Sarcoma Herpesvirus |
| Content Type | Text |
| Resource Type | Article |
| Subject | Cancer Research Oncology |
